T1	Participants 85 128	patients treated with aspirin until surgery
T2	Participants 422 497	prospective, randomized, double-blinded, placebo-controlled, parallel-group
T3	Participants 505 562	Eighty patients were included and divided into two groups
T4	Participants 564 607	one group received tranexamic acid 30 mg/kg
T5	Participants 613 683	one group received placebo (0.9% NaCl) as a bolus injection before CPB
T6	Participants 939 980	The patients in the tranexamic acid group
T7	Participants 1041 1074	the patients in the placebo group
T8	Participants 1187 1222	patients receiving tranexamic acid.
T9	Participants 1686 1700	these patients
